www.fdanews.com/articles/206295-health-canada-approves-seegenes-allplex-covid-19-flu-and-rsv-test
Health Canada Approves Seegene's Allplex COVID-19, Flu and RSV Test
January 25, 2022
Health Canada has granted emergency authorization for Seegene's Allplex SARS CoV-2 FluA/FluB/RSV assay for use during the pandemic.
The multiplex polymerase chain reaction test can detect COVID-19, influenza A or B, or respiratory syncytial virus (RSV) infections in a single test, according to the South Korea-based company.
Seegene has delivered 340,000 tests to Canada and is “fully prepared to supply enough test kits globally,” the company said.